These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26838046)

  • 1. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
    Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
    Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
    Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
    Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.
    Awuah PK; Rhieu BH; Singh S; Misse A; Monga SP
    PLoS One; 2012; 7(6):e39771. PubMed ID: 22761897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation.
    Braeuning A; Heubach Y; Knorpp T; Kowalik MA; Templin M; Columbano A; Schwarz M
    Toxicol Sci; 2011 Sep; 123(1):113-22. PubMed ID: 21705713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
    Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.
    Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP
    J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
    Rignall B; Braeuning A; Buchmann A; Schwarz M
    Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-catenin Mutations Are Not Involved in Early-stage Hepatocarcinogenesis Induced by Protoporphyrinogen Oxidase Inhibitors in Mice.
    Kuwata K; Inoue K; Ichimura R; Takahashi M; Kodama Y; Shibutani M; Yoshida M
    Toxicol Pathol; 2017 Jun; 45(4):493-505. PubMed ID: 28580885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of β-catenin signaling by phenobarbital in hepatoma cells in vitro.
    Groll N; Petrikat T; Vetter S; Wenz C; Dengjel J; Gretzmeier C; Weiss F; Poetz O; Joos TO; Schwarz M; Braeuning A
    Toxicology; 2016 Aug; 370():94-105. PubMed ID: 27693619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor Agonist.
    Mattu S; Saliba C; Sulas P; Zavattari P; Perra A; Kowalik MA; Monga SP; Columbano A
    Am J Pathol; 2018 Nov; 188(11):2497-2507. PubMed ID: 30201494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
    Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17216-21. PubMed ID: 15563600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
    Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
    J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
    Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
    Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway.
    Geter DR; Bhat VS; Gollapudi BB; Sura R; Hester SD
    Toxicol Sci; 2014 Apr; 138(2):425-45. PubMed ID: 24449422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital.
    Sidaway JE; Orton TC; Kalaitzi K; Jones HB; Foster A; Lake BG
    Toxicology; 2020 Jan; 430():152343. PubMed ID: 31836555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
    Gougelet A; Sartor C; Senni N; Calderaro J; Fartoux L; Lequoy M; Wendum D; Talbot JN; Prignon A; Chalaye J; Imbeaud S; Zucman-Rossi J; Tordjmann T; Godard C; Bossard P; Rosmorduc O; Amaddeo G; Colnot S
    Gastroenterology; 2019 Sep; 157(3):807-822. PubMed ID: 31194980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
    Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.
    Zhang Y; Liang B; Song X; Wang H; Evert M; Zhou Y; Calvisi DF; Tang L; Chen X
    Am J Pathol; 2021 May; 191(5):930-946. PubMed ID: 33545120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.